PHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Neupogen is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.Aetna Specialty Pharmacy phone: 1-866-503-0857 Aetna Member Number (claim cannot be processed without number) Group Number If you are enrolled in Medicare, check here Employee Name (First, Middle, Last) Employee Birthdate (MM/DD/YYYY) Employee Address (Street, City, State, ZIP Code) Company Name & Address (Street, City, State, ZIP Code)GR-69025-CA (10-14) Page 1New 08/13 of 2 PRESCRIPTION DRUG PRIOR AUTHORIZATION REQUEST FORM Instructions: Please fill out all applicable sections on both pages completely and legibly . Attach any additional documentation that is1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (continued)"The campaign is intended to make people sit up and think and trigger broader public discussion.” Strange and utterly weird tourism campaigns (and online trolls, for that matter) a...1-866-503-0857 . For other lines of business: Please use other form. Note: Xgeva is non-preferred. The preferred products are pamidronate or zoledronic acid. Pamidronate and zoledronic acid do not require precertification. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date:Synagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.1-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-844-268-7263. PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Vabysmo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use.503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATIONXolair® (omalizumab) Injectable Aetna Precertification Notification. Phone: 1-866-752-7021. Medication Precertification Request . FAX: 1-888-267-3277. Page 1 of 2 For Medicare …"The campaign is intended to make people sit up and think and trigger broader public discussion.” Strange and utterly weird tourism campaigns (and online trolls, for that matter) a...Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Intravenous Immunoglobulins (IVIG) and Adagen are subject to Precertification. If Precertification requirements apply Aetna considers these medications to be medically necessary for those members who meet the following precertification criteria: (see also Appendix A)1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: egible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lucentis and Cimerli are non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Patient First Name1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specificWho is calling or texting from 866-503-0857 phone number? Reverse Phone Lookup registered owner's full name, address, public records & background check for +1 866-503-0857 with Whitepages.Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277. For Oral Corticosteroid Clinical policy click here1-866-503-0857 . For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. Page 1 of 3 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, last ...503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION – Required clinical information must be completed in its entirety for all precertification requests.Page 1 of 3. (All fields must be completed and legible for Precertification Review) Start of treatment: Start date. / /. Continuation of therapy: Date of last treatment / /. 1-855-240-0535 1-877-269-9916. For Medicare Advantage Part B: Phone: 1-866-503-0857.Phone: 1-866-503-0857 (TTY:711) VPRIV ® (velaglucerase alfa) FAX: 1-844-268-7263 . For other lines of business: Medication Precertification Request. Please use other form. Page 2 of 2 Note: Vpriv is non-preferred. The (All fields must be completed and legible for Precertification Review.) preferred products are Cerezyme and Elelyso. Patient ...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start dateMEDICARE FORM. For Medicare Advantage Part B: FAX: 1-844-268-7263. Prolia®, Xgeva® (denosumab) Injectable PHONE: 1-866-503-0857. Medication Precertification Request. For other lines of business: Please use other form. Page 2 of 3. (All fields must be completed and legible for precertification review.)PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product Page 1 of 3 is Eligard. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / /160 Fountain Pkwy N. Suite 200. St. Petersburg, FL 33716-1205. Interested in ordering products from CCS? See how easy it is. Learn More. Contact CCS customer support via email at [email protected] or by phone at 1-888-MEDICAL. Hours of operation: 8:00a.m. - 6:00p.m. ET, Monday-Friday.1-866-503-0857 . For other lines of business: Please use other form. Note: Lucentis is non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257), Mvasi, and Zirabev do not require precertification for ophthalmic use. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment ...1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 Page 2 of 2 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)Aetna Precertification Notification Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment. Precertification...1-866-752-7021 FAX: 1-888-267-3277 . Page 1 of 1 For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment, start date: / / Continuation of therapy,Synagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.If you've missed credit card payments, even if it's been several months, don't panic. You would probably already know if your credit card company had filed a lawsuit. However, many...1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /The form must be completed by the medical staff and submitted to Aetna in the proper state jurisdiction. Fax: 1 (877) 269-9916. Fax (Specialty Drugs): 1 (888) 267-3277. Aetna Specialty Pharmacy phone: 1 (866) 503-0857. All Aetna Forms.Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-7021 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed in its entirety for all precertification requests. Please indicate which eye the treatment is being requested for?1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOBRemicade® (infliximab) Injectable Medication Precertification Request. Page 1 of 5. (All fields must be completed and legible for precertification review.) FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Remicade is preferred for MA plans. Preferred status for.1-866-503-0857. For other lines of business: Please use other form. Note: Granix, Leukine, Neupogen, Nivestym, and Releuko are non-preferred. Zarxio is preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentPharmacy: 866-503-0857; Infusions *For any tests other than those listed call the health plan directly to verify authorization requirements. ... NIA (National Imaging Associates): 866-842-1767/ Prefix WMW thru AIM: 866-688-1449 ; MRI/MRA, CT/CTA, PET, Nuclear Cardiology, All Types of Echos, Infusions *For any tests otherPulmonary Hypertension (Inhalation or Injectable Medication) Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form.Medicare pharmacy (injectable drugs): 1-866-503-0857 ${tty} Non-Medicare plans (includes individual & family plans): 1-888-632-3862 ${tty}, (choose precertification prompt) Non …Video instructions and help with filling out and completing 866 503 0857 Form. Find a suitable template on the Internet. Read all the field labels carefully. Start filling out the blanks according to the instructions:1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 . Zolgensma (onasemnogene abeparvovec-xioi) Medication Precertification Request. Page 1 of 2 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date. Continuation of ...PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Eylea and Eylea HD are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.)This question is about Car Insurance @WalletHub • 12/09/20 This answer was first published on 12/10/20 and it was last updated on 12/09/20.For the most current information about a ...Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: Address: City: ...1-866-503-0857 For other lines of business: Please use other form. Note: Fulphila, Nyvepria, and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. G. CLINICAL INFORMATION (continued) – Required clinical information must be completed in its entirety for all precertification requests. For Initiation requests:Fasenra® (benralizumab) Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Patient First Name.: 1-866-503-0857 . FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Aralast NP, Glassia and Zemaira are non-preferred. The preferred product is Prolastin-C. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of ...PHONE: 1-866-503-0857 . For other lines of business: Please use other form. Note: Remicade is preferred for MA plans. Preferred status for MAPD plans varies based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy:1-866-503-0857 (All fields must be completed and legible for precertification review) Fax: 1-888-267-3277. For Medicare Advantage Part B: Please Use Medicare Request Form . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)A deck renovation is an easy weekend project, other times it can take much more time and money. So be sure of what you need and want before you start. Expert Advice On Improving Yo...MEDICARE FORM. Tremfya® (guselkumab) Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form.Medicare pharmacy (injectable drugs): 1-866-503-0857 ${tty} Non-Medicare plans (includes individual & family plans): 1-888-632-3862 ${tty}, (choose precertification prompt) Non …Diabetic Testing Supplies Prior Authorization Request Form. Diabetic Testing Supplies Prior Authorization Request Form. Ph: (866) 503-0857. Fax: (877) 269-9916. MEMBER INFORMATION Member name. Member ID. Member Address, City, State, ZIP.1-866-503-0857 . For other lines of business: Please use other form . Note: Signifor LAR is non-preferred for acromegaly. The preferred products are Sandostatin LAR and Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last ...Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax:1-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /Precertification Request Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last ...Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: Address: City: ...Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment .Therefore, the airSlate SignNow web application is a must-have for completing and signing 866 503 0857 on the go. In a matter of seconds, receive an electronic document with a legally-binding eSignature. Get 866 752 7021 signed right from your smartphone using these six tips: Type signnow.com in your phone’s browser and log in to your account.. 1-866-752-7021 acetate for depot suspension) FAX: 1-888-261-866-752-7021 Medication Precertification Request FAX Precertification Request Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last ... Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name 1-866-503-0857 For other lines of business: Please use other form. Note: Avsola is preferred for MA plans. Preferred status for MAPD plans varies based on indication. See section G. G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests. Continued on next pagePhone: 1-866-752-7021 FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: Continuation of therapy, date of last treatment: Precertification Requested By: Phone: Fax: 1-866-752-7021 Medication Precertification Re...
Continue Reading